Haoxi Health Technology (HAO) Common Equity (2023 - 2025)

Haoxi Health Technology (HAO) has 3 years of Common Equity data on record, last reported at $17.4 million in Q2 2025.

  • For Q2 2025, Common Equity rose 54.16% year-over-year to $17.4 million; the TTM value through Jun 2025 reached $17.4 million, up 54.16%, while the annual FY2025 figure was $17.4 million, 54.16% up from the prior year.
  • Common Equity reached $17.4 million in Q2 2025 per HAO's latest filing, up from $11.3 million in the prior quarter.
  • Across five years, Common Equity topped out at $17.4 million in Q2 2025 and bottomed at $1.6 million in Q2 2023.
  • Average Common Equity over 3 years is $10.1 million, with a median of $11.3 million recorded in 2024.
  • Peak YoY movement for Common Equity: surged 619.56% in 2024, then skyrocketed 54.16% in 2025.
  • A 3-year view of Common Equity shows it stood at $1.6 million in 2023, then soared by 619.56% to $11.3 million in 2024, then surged by 54.16% to $17.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Common Equity were $17.4 million in Q2 2025, $11.3 million in Q2 2024, and $1.6 million in Q2 2023.